XML 23 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 19,995,447 $ 38,790,603
General and administrative 6,699,481 6,244,408
Total operating expenses 26,694,928 45,035,011
Operating loss (26,694,928) (45,035,011)
Other income (expense):    
Interest income 331,849 667,898
Other financing costs (1,853,189)  
Change in fair value of warrants 3,625,893 (11,837,200)
Total other income (expense), net 2,104,553 (11,169,302)
Net loss $ (24,590,375) $ (56,204,313)
Net loss per share    
Basic (dollars per share) $ (2.02) $ (6.23)
Diluted (dollars per share) $ (2.31) $ (6.23)
Weighted-average number of common shares used in computing net loss per share    
Basic 12,182,475 9,023,138
Diluted 12,235,444 9,023,138